Benefits for Physicians

RTsafe’s innovative technology brings you confidence and control across the entire treatment process. Confirmation of prescribed doses in a simulated environment verifies the efficacy of your plans ahead of treatment execution. As a result, even your most demanding cases (such as multiple brain metastases) become easier to undertake.

Your ability to visualize a patient’s treatment through individualized simulation ensures the desired outcome while simultaneously minimizing the possibility of debilitating side effects. You have the option to share the simulation with the patient, and help them to understand the whole process. In this way, you can provide exceptional patient involvement and empowerment by offering compelling evidence of safe and accurate treatment ahead of a medical intervention.

Additionally, you can store data from the simulation in each patient’s medical record as
proof of good medical practice.

product_pseudopatient

PseudoPatient®

Patient Treatment Verification Redefined. Safety Personalized.

PseudoPatient® is an FDA cleared device constructed by the real patient’s CT data using highly accurate 3D printing technology. It forms an anatomically accurate replica of patient’s head, providing physicians and medical physicists with either direct dose measurements of anatomic regions of high interest (point, 2D), or a full relative 3D dose map, ideal for demanding SRS cases, such as small benign tumors.

Publications

  • Evaluation of an anthropomorphic ion chamber and 3D gel dosimetry head phantom at a 0.35 T MR-linac using separate 1.5 T MR-scanners for gel readout

    Lukas Nierera, Florian Kampab, Michael Reinera, StefanieCorradinia, Moritz Rabea, Olaf Dietrichc, Katia Parodid, Claus Belkaae, Christopher Kurza, Guillaume Landry Journal of Medical Physics (2022)
  • HyperArcTM Dosimetric Validation for Multiple Targets Using Ionization Chamber and RT-100 Polymer Gel

    Lucia Zirone, Elisa Bonanno, Giuseppina Rita Borzì, Nina Cavalli, Alessia D’Anna, Rosaria Galvagno, Andrea Girlando, Anna Maria Gueli, Martina Pace, Giuseppe Stella and Carmelo Marino Gels (2022)

Request a quote

See Whats new at RTsafe

RTsafe to exhibit at ESTRO 2023 in Vienna

RTsafe to exhibit at ESTRO 2023 in Vienna

Conferences - Tradeshows
The annual congress of ESTRO will take place 12-16 May 2023 in Vienna, Austria. ESTRO offers the radiation oncology community the chance...
Read More
RTsafe announces first use of its PseudoPatient patient-specific quality assurance process by Fundación Instituto Valenciano de Oncología (IVO)

RTsafe announces first use of its PseudoPatient patient-specific quality assurance process by Fundación Instituto Valenciano de Oncología (IVO)

Announcements
  Athens, Greece, February 13, 2023   RTsafe, the leading provider of quality assurance products and services in stereotactic radiosurgery, announces that...
Read More
National Funding for the RTsafe project AVATAR

National Funding for the RTsafe project AVATAR

Announcements
We are thrilled to share that the Horizon2020 RTsafe project AVATAR, which received a Seal of Excellence from the European...
Read More
ΕΣΠΑ Banner